Biotech Values

[jaybe]

I know you asked Dew, but I have been compiling the following list of competitors and thought it might be helpful. All listed below provide next-gen sequencing, actionable reporting, and consult for treatment regimen. Only Foundation Medicine and CollabRx (CLRX) are publicly traded.

Foundation Medicine (Foundation One/Heme) http://foundationone.com/
NantHealth (Nantomics) Patrick Soon-Shiong http://nanthealth.com/nantomics/
Caris (Caris Molecular Intelligence) http://www.carismolecularintelligence.com/
Genospace with Pathgroup (SmartGenomics) http://static.squarespace.com/static/541c4fd3e4b000f167fdfe1d/t/544ea536e4b01e689a1a215e/1414440246179/GenoSpace+PatthGroup+case+study.pdf
CollabRx (CancerRx; TherapyFinder) http://www.collabrx.com/products/
MolecularHealth (TreatmentMAP) http://www.molecularhealth.com/oncologists/evidence-based-treatment-strategies/
Personal Genome Diagnostics PGDx (CancerXome) Vogelstein http://www.personalgenome.com/approach.html
SymbioDx (Symgene) http://www.symbiodx.com/ngs
GenomOncology (GO Clinical Workbench) http://www.genomoncology.com/clinical/
N-of-One/Neogenomics (PrecisionWorks/Treatment Roadmap) http://www.n-of-one.com/platform-products/
Syapse/UCSF http://www.syapse.com/blog/ucsf-announces-collaboration-with-syapse-to-power-genomic-medicine-initiative/
MolecularMatch (beta) https://www.molecularmatch.com/learn